From: Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study
Study/Variable | Interpretation | Adjusted odds ratio (95% confidence interval) | |
---|---|---|---|
All subjects | Diabetic patients only | ||
Age | Every 1-year increment | 1.014 (1.012, 1.015) | 1.008 (1.005, 1.011) |
Sex | Men vs. Women | 1.220 (1.171, 1.270) | 1.155 (1.071, 1.247) |
Diabetes | Yes vs. No | 1.133 (1.074, 1.195) | -- |
Panendoscope examination (1997-2005) | Yes vs. No | 8.940 (8.573, 9.321) | 5.592 (5.173, 6.045) |
Hypertension | Yes vs. No | 1.199 (1.129, 1.273) | 1.215 (1.098, 1.345) |
Chronic obstructive pulmonary disease | Yes vs. No | 1.257 (1.202, 1.314) | 1.214 (1.121, 1.313) |
Stroke | Yes vs. No | 1.119 (1.051, 1.191) | 1.096 (1.000, 1.201) |
Nephropathy | Yes vs. No | 1.268 (1.193, 1.347) | 1.314 (1.203, 1.435) |
Ischemic heart disease | Yes vs. No | 1.246 (1.179, 1.317) | 1.183 (1.086, 1.289) |
Peripheral arterial disease | Yes vs. No | 1.126 (1.048, 1.211) | 1.133 (1.025, 1.252) |
Eye disease | Yes vs. No | 0.937 (0.833, 1.053) | 0.898 (0.784, 1.029) |
Obesity | Yes vs. No | 0.971 (0.816, 1.155) | 0.815 (0.627, 1.061) |
Dyslipidemia | Yes vs. No | 1.174 (1.110, 1.242) | 1.034 (0.948, 1.127) |
Statin | Yes vs. No | 1.013 (0.946, 1.086) | 1.015 (0.923, 1.116) |
Fibrate | Yes vs. No | 1.015 (0.944, 1.091) | 1.007 (0.913, 1.110) |
Angiotensin-converting enzyme inhibitor/ Angiotensin receptor blocker | Yes vs. No | 1.011 (0.912, 1.121) | 1.051 (0.913, 1.211) |
Calcium channel blocker | Yes vs. No | 1.147 (1.074, 1.225) | 1.108 (1.004, 1.224) |
Living region | Northern vs. Taipei | 1.103 (1.042, 1.168) | 1.082 (0.968, 1.208) |
Central vs. Taipei | 1.124 (1.056, 1.195) | 1.140 (1.022, 1.271) | |
Southern vs. Taipei | 1.027 (0.969, 1.088) | 1.047 (0.941, 1.165) | |
Kao-Ping/Eastern vs. Taipei | 0.988 (0.924, 1.058) | 0.979 (0.859, 1.116) | |
Occupation | II vs. I | 1.022 (0.961, 1.087) | 1.023 (0.910, 1.148) |
III vs. I | 1.317 (1.235, 1.404) | 1.286 (1.144, 1.445) | |
IV vs. I | 1.308 (1.235, 1.386) | 1.205 (1.080, 1.345) | |
Sulfonylurea | Yes vs. No | - | 0.978 (0.875, 1.093) |
Metformin | Yes vs. No | - | 0.972 (0.867, 1.091) |
Insulin | Yes vs. No | - | 1.414 (1.228, 1.629) |
Acarbose | Yes vs. No | - | 1.004 (0.863, 1.167) |
Pioglitazone | Yes vs. No | - | 0.999 (0.787, 1.269) |
Rosiglitazone | Yes vs. No | - | 0.939 (0.800, 1.101) |